RegenETP Statistics
Total Valuation
RegenETP has a market cap or net worth of $66,386. The enterprise value is -$3.37 million.
| Market Cap | 66,386 |
| Enterprise Value | -3.37M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
RegenETP has 6.85 million shares outstanding.
| Shares Outstanding | 6.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.40% |
| Owned by Institutions (%) | 7.41% |
| Float | 6.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| Forward PS | n/a |
| PB Ratio | 0.01 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 5.70 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,344.91 |
Financial Efficiency
Return on equity (ROE) is -47.14% and return on invested capital (ROIC) is -129.53%.
| Return on Equity (ROE) | -47.14% |
| Return on Assets (ROA) | -34.28% |
| Return on Capital (ROIC) | -129.53% |
| Revenue Per Employee | $19,381 |
| Profits Per Employee | -$186,500 |
| Employee Count | 42 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.79% in the last 52 weeks. The beta is 0.82, so RegenETP's price volatility has been lower than the market average.
| Beta (1Y) | 0.82 |
| 52-Week Price Change | -82.79% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 55.06 |
| Average Volume (30 Days) | n/a |
Short Selling Information
The latest short interest is 120,430, so 1.76% of the outstanding shares have been sold short.
| Short Interest | 120,430 |
| Short Previous Month | 120,601 |
| Short % of Shares Out | 1.76% |
| Short % of Float | 1.81% |
| Short Ratio (days to cover) | 3.19 |
Income Statement
In the last 12 months, RegenETP had revenue of $814,000 and -$7.83 million in losses. Loss per share was -$1.67.
| Revenue | 814,000 |
| Gross Profit | 198,000 |
| Operating Income | -25.88M |
| Pretax Income | -7.83M |
| Net Income | -7.83M |
| EBITDA | -24.29M |
| EBIT | -25.79M |
| Loss Per Share | -$1.67 |
Balance Sheet
The company has $6.39 million in cash and $2.95 million in debt, giving a net cash position of $3.44 million or $0.50 per share.
| Cash & Cash Equivalents | 6.39M |
| Total Debt | 2.95M |
| Net Cash | 3.44M |
| Net Cash Per Share | $0.50 |
| Equity / Book Value | 12.42M |
| Book Value Per Share | 1.81 |
| Working Capital | 6.76M |
Cash Flow
In the last 12 months, operating cash flow was -$4.09 million and capital expenditures $216,000, giving a free cash flow of -$22.63 million.
| Operating Cash Flow | -4.09M |
| Capital Expenditures | 216,000 |
| Free Cash Flow | -22.63M |
| FCF Per Share | -$3.30 |
Margins
Gross margin is 24.32%, with operating and profit margins of -3,178.99% and -962.29%.
| Gross Margin | 24.32% |
| Operating Margin | -3,178.99% |
| Pretax Margin | -962.29% |
| Profit Margin | -962.29% |
| EBITDA Margin | -2,983.66% |
| EBIT Margin | -3,168.80% |
| FCF Margin | -2,780.59% |
Dividends & Yields
RegenETP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -114.12% |
| Shareholder Yield | -114.12% |
| Earnings Yield | -11,799.17% |
| FCF Yield | -34,094.54% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 17, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | May 17, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
RegenETP has an Altman Z-Score of -44.26 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -44.26 |
| Piotroski F-Score | 1 |